 |
PDBsum entry 5osc
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transport protein
|
PDB id
|
|
|
|
5osc
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Crystal structures of a gabaa-Receptor chimera reveal new endogenous neurosteroid-Binding sites.
|
 |
|
Authors
|
 |
D.Laverty,
P.Thomas,
M.Field,
O.J.Andersen,
M.G.Gold,
P.C.Biggin,
M.Gielen,
T.G.Smart.
|
 |
|
Ref.
|
 |
Nat Struct Mol Biol, 2017,
24,
977-985.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
γ-Aminobutyric acid receptors (GABAARs) are vital for controlling
excitability in the brain. This is emphasized by the numerous neuropsychiatric
disorders that result from receptor dysfunction. A critical component of most
native GABAARs is the α subunit. Its transmembrane domain is the
target for many modulators, including endogenous brain neurosteroids that impact
anxiety, stress and depression, and for therapeutic drugs, such as general
anesthetics. Understanding the basis for the modulation of GABAAR
function requires high-resolution structures. Here we present the first atomic
structures of a GABAAR chimera at 2.8-Å resolution, including those
bound with potentiating and inhibitory neurosteroids. These structures define
new allosteric binding sites for these modulators that are associated with the
α-subunit transmembrane domain. Our findings will enable the exploitation of
neurosteroids for therapeutic drug design to regulate GABAARs in
neurological disorders.
|
 |
|
|
|
|
 |